Selected research
Market Structure
Global Home Parenteral Nutrition (HPN) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Home Parenteral Nutrition (HPN) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Home Parenteral Nutrition (HPN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Home Parenteral Nutrition (HPN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Home Parenteral Nutrition (HPN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Home Parenteral Nutrition (HPN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Home Parenteral Nutrition (HPN) include B. Braun Melsungen, Grifols International, Otsuka Pharmaceutical, Sichuan Kelun Pharmaceutical, Teva Pharmaceutical, Baxter, Fresenius Kabi, Pfizer and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Home Parenteral Nutrition (HPN) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Home Parenteral Nutrition (HPN) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Home Parenteral Nutrition (HPN) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Home Parenteral Nutrition (HPN) market size, projected growth trends, production technologies, key applications, and end-use industries.
Home Parenteral Nutrition (HPN) Segment by Company
B. Braun Melsungen
Grifols International
Otsuka Pharmaceutical
Sichuan Kelun Pharmaceutical
Teva Pharmaceutical
Baxter
Fresenius Kabi
Pfizer
Takeda
Home Parenteral Nutrition (HPN) Segment by Type
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Carbohydrates
Trace Elements
Vitamins and Minerals
Home Parenteral Nutrition (HPN) Segment by Application
Neonates
Chronic Disease Patients
Geriatrics
Home Parenteral Nutrition (HPN) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Parenteral Nutrition (HPN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Home Parenteral Nutrition (HPN) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Parenteral Nutrition (HPN).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Home Parenteral Nutrition (HPN) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Home Parenteral Nutrition (HPN) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Home Parenteral Nutrition (HPN) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Home Parenteral Nutrition (HPN) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Parenteral Lipid Emulsion
- Single Dose Amino Acid Solution
- Carbohydrates
- Trace Elements
- Vitamins and Minerals
Applications
- Neonates
- Chronic Disease Patients
- Geriatrics
Companies covered
- B. Braun Melsungen
- Grifols International
- Otsuka Pharmaceutical
- Sichuan Kelun Pharmaceutical
- Teva Pharmaceutical
- Baxter
- Fresenius Kabi
- Pfizer
- Takeda
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Home Parenteral Nutrition (HPN) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Home Parenteral Nutrition (HPN) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Home Parenteral Nutrition (HPN) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Home Parenteral Nutrition (HPN) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Home Parenteral Nutrition (HPN) Market Dynamics
- 2.1 Home Parenteral Nutrition (HPN) Industry Trends
- 2.2 Home Parenteral Nutrition (HPN) Industry Drivers
- 2.3 Home Parenteral Nutrition (HPN) Industry Opportunities and Challenges
- 2.4 Home Parenteral Nutrition (HPN) Industry Restraints
3 Home Parenteral Nutrition (HPN) Market by Manufacturers
- 3.1 Global Home Parenteral Nutrition (HPN) Revenue by Manufacturers (2021-2026)
- 3.2 Global Home Parenteral Nutrition (HPN) Sales by Manufacturers (2021-2026)
- 3.3 Global Home Parenteral Nutrition (HPN) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Home Parenteral Nutrition (HPN) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Home Parenteral Nutrition (HPN) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Home Parenteral Nutrition (HPN) Manufacturers, Product Type & Application
- 3.7 Global Home Parenteral Nutrition (HPN) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Home Parenteral Nutrition (HPN) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Home Parenteral Nutrition (HPN) Players Market Share by Revenue in 2025
- 3.8.3 2025 Home Parenteral Nutrition (HPN) Tier 1, Tier 2, and Tier 3
4 Home Parenteral Nutrition (HPN) Market by Type
- 4.1 Home Parenteral Nutrition (HPN) Type Introduction
- 4.1.1 Parenteral Lipid Emulsion
- 4.1.2 Single Dose Amino Acid Solution
- 4.1.3 Carbohydrates
- 4.1.4 Trace Elements
- 4.1.5 Vitamins and Minerals
- 4.2 Global Home Parenteral Nutrition (HPN) Sales by Type
- 4.2.1 Global Home Parenteral Nutrition (HPN) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Home Parenteral Nutrition (HPN) Sales by Type (2021-2032)
- 4.2.3 Global Home Parenteral Nutrition (HPN) Sales Market Share by Type (2021-2032)
- 4.3 Global Home Parenteral Nutrition (HPN) Revenue by Type
- 4.3.1 Global Home Parenteral Nutrition (HPN) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Home Parenteral Nutrition (HPN) Revenue by Type (2021-2032)
- 4.3.3 Global Home Parenteral Nutrition (HPN) Revenue Market Share by Type (2021-2032)
5 Home Parenteral Nutrition (HPN) Market by Application
- 5.1 Home Parenteral Nutrition (HPN) Application Introduction
- 5.1.1 Neonates
- 5.1.2 Chronic Disease Patients
- 5.1.3 Geriatrics
- 5.2 Global Home Parenteral Nutrition (HPN) Sales by Application
- 5.2.1 Global Home Parenteral Nutrition (HPN) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Home Parenteral Nutrition (HPN) Sales by Application (2021-2032)
- 5.2.3 Global Home Parenteral Nutrition (HPN) Sales Market Share by Application (2021-2032)
- 5.3 Global Home Parenteral Nutrition (HPN) Revenue by Application
- 5.3.1 Global Home Parenteral Nutrition (HPN) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Home Parenteral Nutrition (HPN) Revenue by Application (2021-2032)
- 5.3.3 Global Home Parenteral Nutrition (HPN) Revenue Market Share by Application (2021-2032)
6 Global Home Parenteral Nutrition (HPN) Sales by Region
- 6.1 Global Home Parenteral Nutrition (HPN) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Home Parenteral Nutrition (HPN) Sales by Region (2021-2032)
- 6.2.1 Global Home Parenteral Nutrition (HPN) Sales by Region (2021-2026)
- 6.2.2 Global Home Parenteral Nutrition (HPN) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Home Parenteral Nutrition (HPN) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Home Parenteral Nutrition (HPN) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Home Parenteral Nutrition (HPN) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Home Parenteral Nutrition (HPN) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Home Parenteral Nutrition (HPN) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Home Parenteral Nutrition (HPN) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Home Parenteral Nutrition (HPN) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Home Parenteral Nutrition (HPN) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Home Parenteral Nutrition (HPN) Revenue by Region
- 7.1 Global Home Parenteral Nutrition (HPN) Revenue by Region
- 7.1.1 Global Home Parenteral Nutrition (HPN) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Home Parenteral Nutrition (HPN) Revenue by Region (2021-2026)
- 7.1.3 Global Home Parenteral Nutrition (HPN) Revenue by Region (2027-2032)
- 7.1.4 Global Home Parenteral Nutrition (HPN) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Home Parenteral Nutrition (HPN) Revenue (2021-2032)
- 7.2.2 North America Home Parenteral Nutrition (HPN) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Home Parenteral Nutrition (HPN) Revenue (2021-2032)
- 7.3.2 Europe Home Parenteral Nutrition (HPN) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Home Parenteral Nutrition (HPN) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Home Parenteral Nutrition (HPN) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Home Parenteral Nutrition (HPN) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Home Parenteral Nutrition (HPN) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 B. Braun Melsungen
- 8.1.1 B. Braun Melsungen Company Information
- 8.1.2 B. Braun Melsungen Business Overview
- 8.1.3 B. Braun Melsungen Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 B. Braun Melsungen Home Parenteral Nutrition (HPN) Product Portfolio
- 8.1.5 B. Braun Melsungen Recent Developments
- 8.2 Grifols International
- 8.2.1 Grifols International Company Information
- 8.2.2 Grifols International Business Overview
- 8.2.3 Grifols International Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Grifols International Home Parenteral Nutrition (HPN) Product Portfolio
- 8.2.5 Grifols International Recent Developments
- 8.3 Otsuka Pharmaceutical
- 8.3.1 Otsuka Pharmaceutical Company Information
- 8.3.2 Otsuka Pharmaceutical Business Overview
- 8.3.3 Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
- 8.3.5 Otsuka Pharmaceutical Recent Developments
- 8.4 Sichuan Kelun Pharmaceutical
- 8.4.1 Sichuan Kelun Pharmaceutical Company Information
- 8.4.2 Sichuan Kelun Pharmaceutical Business Overview
- 8.4.3 Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
- 8.4.5 Sichuan Kelun Pharmaceutical Recent Developments
- 8.5 Teva Pharmaceutical
- 8.5.1 Teva Pharmaceutical Company Information
- 8.5.2 Teva Pharmaceutical Business Overview
- 8.5.3 Teva Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Teva Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
- 8.5.5 Teva Pharmaceutical Recent Developments
- 8.6 Baxter
- 8.6.1 Baxter Company Information
- 8.6.2 Baxter Business Overview
- 8.6.3 Baxter Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Baxter Home Parenteral Nutrition (HPN) Product Portfolio
- 8.6.5 Baxter Recent Developments
- 8.7 Fresenius Kabi
- 8.7.1 Fresenius Kabi Company Information
- 8.7.2 Fresenius Kabi Business Overview
- 8.7.3 Fresenius Kabi Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Fresenius Kabi Home Parenteral Nutrition (HPN) Product Portfolio
- 8.7.5 Fresenius Kabi Recent Developments
- 8.8 Pfizer
- 8.8.1 Pfizer Company Information
- 8.8.2 Pfizer Business Overview
- 8.8.3 Pfizer Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Pfizer Home Parenteral Nutrition (HPN) Product Portfolio
- 8.8.5 Pfizer Recent Developments
- 8.9 Takeda
- 8.9.1 Takeda Company Information
- 8.9.2 Takeda Business Overview
- 8.9.3 Takeda Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Takeda Home Parenteral Nutrition (HPN) Product Portfolio
- 8.9.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Home Parenteral Nutrition (HPN) Value Chain Analysis
- 9.1.1 Home Parenteral Nutrition (HPN) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Home Parenteral Nutrition (HPN) Production Mode & Process
- 9.2 Home Parenteral Nutrition (HPN) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Home Parenteral Nutrition (HPN) Distributors
- 9.2.3 Home Parenteral Nutrition (HPN) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst